{"id":12289,"date":"2024-10-11T23:59:21","date_gmt":"2024-10-11T21:59:21","guid":{"rendered":"https:\/\/valintermed.com\/?p=12289"},"modified":"2024-10-11T23:59:21","modified_gmt":"2024-10-11T21:59:21","slug":"tyazhelyy-giperparatireoz-u-novorozhdennyh","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/tyazhelyy-hyperparathyroidism-in-newborns\/","title":{"rendered":"Severe hyperparathyroidism in newborns"},"content":{"rendered":"
<\/div>\n

Severe hyperparathyroidism in neonates is a rare but serious endocrine disorder characterized by increased production of parathyroid hormone, which leads to an imbalance of calcium and phosphorus in the body. This condition is caused by hyperplasia or tumors of the parathyroid glands, which in turn leads to an increase in the concentration of calcium in the blood plasma (hypercalcemia). Symptoms of severe hyperparathyroidism in neonates can manifest through various clinical manifestations, including neuromuscular conduction disorders, growth retardation, and renal and bone abnormalities. The pathology can lead to serious consequences, including osteoporosis, renal failure, and even death if not diagnosed and treated promptly.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n